1 – 10 of 15
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Spatial tumor immune microenvironment phenotypes in ovarian cancer
(
- Contribution to journal › Article
- 2023
-
Mark
Is lung involvement a favorable prognostic factor for pancreatic ductal adenocarcinoma with synchronous liver metastases?—A propensity score analysis
2023) In Expert Review of Gastroenterology and Hepatology(
- Contribution to journal › Article
-
Mark
Overexpression of the key metabolic protein CPT1A defines mantle cell lymphoma patients with poor response to standard high dose chemotherapy independent of MIPI and complement established high-risk factors
(
- Contribution to journal › Article
-
Mark
Systemic chemotherapy with or without hepatic arterial infusion chemotherapy for liver metastases from pancreatic cancer: a propensity score matching analysis
(
- Contribution to journal › Article
-
Mark
Phenotypic characterization of spatial immune infiltration niches in non-small cell lung cancer
(
- Contribution to journal › Article
- 2021
-
Mark
Large Extracellular Vesicle Characterization and Association with Circulating Tumor Cells in Metastatic Castrate Resistant Prostate Cancer
(
- Contribution to journal › Article
- 2016
-
Mark
Plasma protein profiling in a stage defined pancreatic cancer cohort – Implications for early diagnosis
(
- Contribution to journal › Article
-
Mark
Evaluation of Solid Supports for Slide- and Well-Based Recombinant Antibody Microarrays
(
- Contribution to journal › Article
- 2015
-
Mark
A Multicenter Trial Defining a Serum Protein Signature Associated with Pancreatic Ductal Adenocarcinoma.
(
- Contribution to journal › Article
-
Mark
Interfacing antibody-based microarrays and digital holography enables label-free detection for loss of cell volume
2015) In Future science OA(
- Contribution to journal › Article